Parkinson's disease fatigability and its correction with the dopamine receptor agonist pramipexole
Fatigability is a common nonmotor symptom in Parkinson's disease (PD), which worsens quality of life in patients. Objective: to analyze the association of fatigability with the duration of PD and the degree of movement and neuropsychic (depression, nocturnal sleep disorders, daytime sleepiness)...
Main Author: | M. R. Nodel |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2011-12-01
|
Series: | Nevrologiâ, Nejropsihiatriâ, Psihosomatika |
Subjects: | |
Online Access: | https://nnp.ima-press.net/nnp/article/view/101 |
Similar Items
-
Capacities of the dopamine receptor agonist pramipexole in the treatment of patients with Parkinson’s disease
by: S N Illarioshkin
Published: (2012-06-01) -
Role and clinical utility of pramipexole extended release in the treatment of early Parkinson's disease
by: Hametner EM, et al.
Published: (2012-03-01) -
Occupancy of pramipexole (Sifrol) at cerebral dopamine D2/3 receptors in Parkinson's disease patients
by: Angela Deutschländer, et al.
Published: (2016-01-01) -
Sleep disorders in Parkinson's disease
by: M. R. Nodel
Published: (2011-03-01) -
Analysis of pramipexole dose–response relationships in Parkinson's disease
by: Wang Y, et al.
Published: (2016-12-01)